These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17548949)

  • 1. [A case of peripheral facial nerve palsy with cryoglobulinemia and chronic thyroiditis occurring during interferon plus ribavirin therapy for chronic hepatitis C].
    Sumida Y; Kanemasa K; Fukumoto K; Yoshida N; Sakai K
    Nihon Shokakibyo Gakkai Zasshi; 2007 Jun; 104(6):815-21. PubMed ID: 17548949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid dysfunction during interferon alpha therapy for chronic hepatitis C.
    Shen L; Bui C; Mansberg R; Nguyen D; Alam-Fotias S
    Clin Nucl Med; 2005 Aug; 30(8):546-7. PubMed ID: 16024950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
    Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F
    Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
    Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
    Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
    Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
    Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.
    Mazzaro C; Zorat F; Caizzi M; Donada C; Di Gennaro G; Maso LD; Carniello G; Virgolini L; Tirelli U; Pozzato G
    J Hepatol; 2005 May; 42(5):632-8. PubMed ID: 15826710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An extremely rare case of delusional parasitosis in a chronic hepatitis C patient during pegylated interferon alpha-2b and ribavirin treatment.
    Robaeys G; De Bie J; Van Ranst M; Buntinx F
    World J Gastroenterol; 2007 Apr; 13(16):2379-80. PubMed ID: 17511042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
    Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
    Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin].
    Kim YH; Han WS; Lee SJ; Oh SN; Choi DW; Byun KS; Yeon JE
    Korean J Hepatol; 2007 Sep; 13(3):419-22. PubMed ID: 17898559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
    Callens S; Bottieau E; Michielsen P; Colebunders R
    AIDS; 2004 Jan; 18(1):131. PubMed ID: 15090841
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experience. Ribavirin-Interferon in Chronic Hepatitis Italian Group Investigators.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Pellicelli A; Grisorio B; Barbarini G
    J Hepatol; 2000 Sep; 33(3):448-55. PubMed ID: 11020001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial.
    Poynard T; Marcellin P; Bissery A; Myers RP; Moussalli J; Degos F; Dhumeaux D; Riachi G; Bronowicki JP; Brissot P; Buffet C; Serfaty L; Naveau S; Sogni P; Beaugrand M; Gayno S; Larrey D; Samuel D; Eugene C; Pol S; Bedossa P; Daurat V; Chaumet-Riffaud P;
    J Viral Hepat; 2003 May; 10(3):197-204. PubMed ID: 12753338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin--a review.
    Andrade LJ; Atta AM; D'Almeida Junior A; Paraná R
    Braz J Infect Dis; 2008 Apr; 12(2):144-8. PubMed ID: 18641852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of cardiac sarcoidosis occurring during combination therapy by IFN alpha and ribavirin for chronic hepatitis C].
    Iwashita M; Maeda T; Tagami A; Watanabe N; Takada J; Asano T; Hatakeyama H; Hayashi T; Nishiwaki S; Saito K
    Nihon Shokakibyo Gakkai Zasshi; 2010 Aug; 107(8):1319-27. PubMed ID: 20693757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis.
    Kim SR; Imoto S; Mita K; Taniguchi M; Sasase N; Muramatsu A; Kudo M; Kitai S; El-Shamy A; Hotta H; Hayashi Y
    Digestion; 2009; 79(1):36-9. PubMed ID: 19246919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C.
    Sjogren MH; Sjogren R; Holtzmuller K; Winston B; Butterfield B; Drake S; Watts A; Howard R; Smith M
    Dig Dis Sci; 2005 Apr; 50(4):727-32. PubMed ID: 15844709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of Bell's palsy associated with peginterferon Alfa-2a and ribavirin therapy for chronic hepatitis C virus infection].
    Lee MY; Cho H; Kim YM; Lee JS
    Korean J Hepatol; 2006 Sep; 12(3):444-8. PubMed ID: 16998297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine.
    Pérez-Alvarez R; Pérez-López R; Lombraña JL; Rodríguez M; Rodrigo L
    J Viral Hepat; 2002 Jan; 9(1):75-9. PubMed ID: 11851906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peripheral facial paralysis during interferon treatment in hepatitis C: recovery without antiviral therapy withdrawal].
    de Artaza T; Sánchez JJ; González C; Pérez-Grueso MJ; Repiso A; Gómez R; Potenciano JL
    Gastroenterol Hepatol; 2004; 27(7):434-5. PubMed ID: 15461949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.